Targeted delivery of nucleic-acid-based therapeutics to the pulmonary circulation.
about
Efficient Biodistribution and Gene Silencing in the Lung epithelium via Intravenous Liposomal Delivery of siRNA.Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNATargeted siRNA delivery to diseased microvascular endothelial cells: cellular and molecular concepts.Delivery of therapeutic siRNA to the lung endothelium via novel Lipoplex formulation DACC.Oligonucleotide Therapy for Obstructive and Restrictive Respiratory Diseases.
P2860
Targeted delivery of nucleic-acid-based therapeutics to the pulmonary circulation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeted delivery of nucleic-acid-based therapeutics to the pulmonary circulation.
@en
Targeted delivery of nucleic-acid-based therapeutics to the pulmonary circulation.
@nl
type
label
Targeted delivery of nucleic-acid-based therapeutics to the pulmonary circulation.
@en
Targeted delivery of nucleic-acid-based therapeutics to the pulmonary circulation.
@nl
prefLabel
Targeted delivery of nucleic-acid-based therapeutics to the pulmonary circulation.
@en
Targeted delivery of nucleic-acid-based therapeutics to the pulmonary circulation.
@nl
P2093
P2860
P1433
P1476
Targeted delivery of nucleic-acid-based therapeutics to the pulmonary circulation.
@en
P2093
Annette Wilson
Ramalinga Kuruba
P2860
P2888
P356
10.1208/S12248-008-9073-0
P407
P577
2009-01-09T00:00:00Z
P5875
P6179
1018384182